Skip to main content
VITA LIFE SCIENCES LIMITED.. logo

VITA LIFE SCIENCES LIMITED.. — Investor Relations & Filings

Ticker · VLS ISIN · AU000000VLS8 ASX Manufacturing
Open in API
Filings indexed 1,057 across all filing types
Latest filing 2025-12-16 Director's Dealing
Country AU Australia
Listing ASX VLS

About VITA LIFE SCIENCES LIMITED..

https://vitalifesciences.com/

Vita Life Sciences Limited is a healthcare company focused on the development, marketing, and distribution of vitamins, minerals, and nutritional supplements. The company operates primarily through its core brands, including VitaHealth and Herbs of Gold, offering a diverse range of health products designed to support general well-being, immunity, and specific health concerns. Its product portfolio encompasses herbal medicines, dietary supplements, and functional foods formulated using evidence-based research and high-quality ingredients. The company maintains a significant presence across the Asia-Pacific region, serving markets in Southeast Asia and Oceania. By leveraging a multi-channel distribution strategy, including pharmacies, health food stores, and online platforms, the company provides accessible health solutions to a broad consumer base.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 3 pages 1.2MB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including direct and indirect interests, dates of changes, and nature of transactions. This type of document is a formal notification of personal share transactions by company directors, commonly known as a director's dealing notice. It does not contain financial performance data, management discussion, or other report content. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is not a brief announcement or a report publication notice but the actual notice of director's interest change.
2025-12-16 English
Profit Guidance 1 page 660.8KB
Regulatory Filings Classification · 95% confidence The document is a market announcement dated December 12, 2025, providing forward-looking financial guidance for the full fiscal year ending December 31, 2025. It includes projected sales and pre-tax profit figures, along with commentary on market performance and strategic investments. The document does not contain actual financial statements or detailed financial results, nor does it present a full annual or interim report. It is a brief announcement focused on guidance rather than reporting past results. Given the short length (2062 characters) and the nature of the content (guidance announcement), it does not qualify as an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement providing financial guidance without detailed financial data or formal report structure.
2025-12-11 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about the company's on-market buy-back program, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement specifically about the company's repurchase of its own shares. This matches the description of 'Transaction in Own Shares' filings, which report on share repurchase activities. The document is about 5374 characters long, contains substantive data about the buy-back, and is not merely an announcement of a report or a certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2025-12-10 English
Notification of cessation of securities - VLS 4 pages 14.7KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of securities due to cancellation pursuant to an on-market buy-back. It includes specific information about the number of securities ceased, consideration paid, and updated issued capital figures. The document is an official announcement related to changes in the company's issued capital, specifically the cessation of securities. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares. The document length is 3823 characters, which is consistent with a detailed announcement rather than a brief notice or a full financial report. Therefore, the appropriate classification is POS with high confidence.
2025-12-09 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a company's on-market buy-back program, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement related to the company's repurchase of its own shares. This matches the description of 'Transaction in Own Shares' filings, which report the company buying back or selling its own shares. The document is not a full financial report, earnings release, or management discussion, but a specific buy-back notification. Therefore, the appropriate classification is POS (Transaction in Own Shares). The document length and detail support a high confidence level.
2025-12-04 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a daily buy-back notification by Vita Life Sciences Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and regulatory references to ASX listing rules. The content is focused on reporting the company's share repurchase activity rather than financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buy-back of its own shares. The document length is over 5,000 characters and contains substantive details about the buy-back, confirming it is not merely an announcement of a report but the actual notification itself.
2025-11-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.